Sumitomo Pharma Co., Ltd. (DNPUF)

Market Cap	2.78B
Revenue (ttm)	2.66B
Net Income (ttm)	157.83M
Shares Out	n/a
EPS (ttm)	0.40
PE Ratio	17.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	423
Open	6.48
Previous Close	n/a
Day's Range	6.34 - 6.48
52-Week Range	2.42 - 6.55
Beta	0.54
RSI	66.03
Earnings Date	Jul 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical anti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: OTCMKTS
• Ticker Symbol: DNPUF

Financial Performance

Financial numbers in JPY